Berdazimer Sodium Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as LNHC. It is marketed under 1 brand name, including ZELSUVMI. Available in 1 different strength, such as EQ 10.3% BASE, and administered through 1 route including GEL;TOPICAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"120646","ingredient":"BERDAZIMER SODIUM","trade_name":"ZELSUVMI","family_id":"26424943761547b4a08e","publication_number":"US8956658B2","cleaned_patent_number":"8956658","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-05-30","publication_date":"2015-02-17","legal_status":"Patented case"} US8956658B2 Molecular 17 Feb, 2015 Patented case 30 May, 2026
{"application_id":"120657","ingredient":"BERDAZIMER SODIUM","trade_name":"ZELSUVMI","family_id":"26424943761547b4a08e","publication_number":"US8282967B2","cleaned_patent_number":"8282967","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-05-30","publication_date":"2012-10-09","legal_status":"Patented case"} US8282967B2 Molecular 09 Oct, 2012 Patented case 30 May, 2026
{"application_id":"120675","ingredient":"BERDAZIMER SODIUM","trade_name":"ZELSUVMI","family_id":"05b8e344dca7428ea8b3","publication_number":"US9737561B2","cleaned_patent_number":"9737561","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-08-20","publication_date":"2017-08-22","legal_status":"Granted"} US9737561B2 22 Aug, 2017 Granted 20 Aug, 2030
{"application_id":"120667","ingredient":"BERDAZIMER SODIUM","trade_name":"ZELSUVMI","family_id":"05b8e344dca7428ea8b3","publication_number":"US10376538B2","cleaned_patent_number":"10376538","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-08-20","publication_date":"2019-08-13","legal_status":"Granted"} US10376538B2 Formulation 13 Aug, 2019 Granted 20 Aug, 2030
{"application_id":"120674","ingredient":"BERDAZIMER SODIUM","trade_name":"ZELSUVMI","family_id":"05b8e344dca7428ea8b3","publication_number":"US9526738B2","cleaned_patent_number":"9526738","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-09-03","publication_date":"2016-12-27","legal_status":"Granted"} US9526738B2 Formulation 27 Dec, 2016 Granted 03 Sep, 2031
{"application_id":"120686","ingredient":"BERDAZIMER SODIUM","trade_name":"ZELSUVMI","family_id":"3a51f0ba1e274159b73b","publication_number":"US9289442B2","cleaned_patent_number":"9289442","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-07-03","publication_date":"2016-03-22","legal_status":"Granted"} US9289442B2 Formulation 22 Mar, 2016 Granted 03 Jul, 2032
{"application_id":"120680","ingredient":"BERDAZIMER SODIUM","trade_name":"ZELSUVMI","family_id":"3a51f0ba1e274159b73b","publication_number":"US10265334B2","cleaned_patent_number":"10265334","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-07-03","publication_date":"2019-04-23","legal_status":"Granted"} US10265334B2 Formulation 23 Apr, 2019 Granted 03 Jul, 2032
{"application_id":"120639","ingredient":"BERDAZIMER SODIUM","trade_name":"ZELSUVMI","family_id":"53efffaba67d4fac81c5","publication_number":"US9855211B2","cleaned_patent_number":"9855211","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-02-27","publication_date":"2018-01-02","legal_status":"Granted"} US9855211B2 Formulation 02 Jan, 2018 Granted 27 Feb, 2034
{"application_id":"120627","ingredient":"BERDAZIMER SODIUM","trade_name":"ZELSUVMI","family_id":"53efffaba67d4fac81c5","publication_number":"US11285098B2","cleaned_patent_number":"11285098","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-02-28","publication_date":"2022-03-29","legal_status":"Granted"} US11285098B2 Formulation 29 Mar, 2022 Granted 28 Feb, 2034
{"application_id":"120640","ingredient":"BERDAZIMER SODIUM","trade_name":"ZELSUVMI","family_id":"53efffaba67d4fac81c5","publication_number":"US10258564B2","cleaned_patent_number":"10258564","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-22","publication_date":"2019-04-16","legal_status":"Granted"} US10258564B2 16 Apr, 2019 Granted 22 Nov, 2034
{"application_id":"122889","ingredient":"BERDAZIMER SODIUM","trade_name":"ZELSUVMI","family_id":"","publication_number":"US11723858B2","cleaned_patent_number":"11723858","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-07-10","publication_date":"2023-08-15","legal_status":"Granted"} US11723858B2 Formulation 15 Aug, 2023 Granted 10 Jul, 2035
{"application_id":"122890","ingredient":"BERDAZIMER SODIUM","trade_name":"ZELSUVMI","family_id":"","publication_number":"US11040006B2","cleaned_patent_number":"11040006","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-07-10","publication_date":"2021-06-22","legal_status":"Granted"} US11040006B2 Formulation 22 Jun, 2021 Granted 10 Jul, 2035
{"application_id":"122891","ingredient":"BERDAZIMER SODIUM","trade_name":"ZELSUVMI","family_id":"","publication_number":"US10736839B2","cleaned_patent_number":"10736839","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-07-10","publication_date":"2020-08-11","legal_status":"Granted"} US10736839B2 11 Aug, 2020 Granted 10 Jul, 2035
{"application_id":"122892","ingredient":"BERDAZIMER SODIUM","trade_name":"ZELSUVMI","family_id":"","publication_number":"US10322081B2","cleaned_patent_number":"10322081","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-07-10","publication_date":"2019-06-18","legal_status":"Granted"} US10322081B2 18 Jun, 2019 Granted 10 Jul, 2035

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Berdazimer Sodium

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.